论文部分内容阅读
总结２９２例多结节性肝癌的治疗。全身化疗１１１例，肝动脉栓塞化疗５８例，多次局切６７例，局切后并用肝动脉、门静脉插管化疗５６例。结果：ＡＦＰ转阴率分别为０、３８．１％、７４．５％、８４．６％；各组１、２、３、５年生存率分别为１８．２％、４５．６％、５２．２％、５３．８％；１．９％、３８．９％、２５．８％、５０．９％；０、７．５％、２０．３％、４６．３％；０、１．９％、５．２％、１７．３％。提示，多结节性肝癌手术切除优于药物治疗，切除后并用肝动脉、门静脉插管化疗优于单纯局切，非手术治疗者。碘油抗癌药物乳化液栓塞治疗优于全身化疗（Ｐ均＜０．０５）。
Summarize the treatment of 292 cases of multi-nodular liver cancer. There were 111 cases of systemic chemotherapy, 58 cases of hepatic artery embolization chemotherapy, 67 cases of multiple incisors, and 56 cases of hepatic arterial and portal vein intubation chemotherapy. Results: The AFP negative rate was 0, 38.1%, 74.5%, 84.6%, respectively; the 1, 2, 3, and 5-year survival rates in each group were 18.2%, 45.6%, and 52 respectively. .2%, 53.8%; 1.9%, 38.9%, 25.8%, 50.9%; 0, 7.5%, 20.3%, 46.3%; 0, 1. 9%, 5.2%, 17.3%. It is suggested that surgical resection of multinodular hepatocellular carcinoma is superior to drug therapy, and that hepatic arterial and portal vein catheterization after resection is superior to intubation and non-surgical treatment. Lipiodol anticancer drug emulsion embolization was superior to systemic chemotherapy (P all < 0.05).